|
Your search returned 250 studies:
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-28207
Conditions: Type 2 Diabetes Mellitus
Location: Charlotte, NC
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-30076
Conditions: Type 2 Diabetes Mellitus
Location: Roswell, GA
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-30909
Conditions: Type 2 Diabetes Mellitus
Location: Augusta, GA
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-31501
Conditions: Type 2 Diabetes Mellitus
Location: Waycross, GA
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-35661
Conditions: Type 2 Diabetes Mellitus
Location: Muscle Shoals, AL
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-36109
Conditions: Type 2 Diabetes Mellitus
Location: Montgomery, AL
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-37207
Conditions: Type 2 Diabetes Mellitus
Location: Brentwood, TN
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-47714
Conditions: Type 2 Diabetes Mellitus
Location: Evansville, IN
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-49079
Conditions: Type 2 Diabetes Mellitus
Location: Paw Paw, MI
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-59701
Conditions: Type 2 Diabetes Mellitus
Location: Butte, MT
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-60611
Conditions: Type 2 Diabetes Mellitus
Location: Chicago, IL
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-60616
Conditions: Type 2 Diabetes Mellitus
Location: Chicago, IL
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-63031
Conditions: Type 2 Diabetes Mellitus
Location: Florissant, MO
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-70808
Conditions: Type 2 Diabetes Mellitus
Location: Baton Rouge, LA
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-75230
Conditions: Type 2 Diabetes Mellitus
Location: Dallas, TX
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-78229
Conditions: Type 2 Diabetes Mellitus
Location: San Antonio, TX
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-85206
Conditions: Type 2 Diabetes Mellitus
Location: Mesa, AZ
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-90723
Conditions: Type 2 Diabetes Mellitus
Location: Paramount, CA
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-92801
Conditions: Type 2 Diabetes Mellitus
Location: Anaheim, CA
- 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 - NCT00976937-97504
Conditions: Type 2 Diabetes Mellitus
Location: Medford, OR
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-08822
Conditions: Type 2 Diabetes Mellitus
Location: Flemington, NJ
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-19146
Conditions: Type 2 Diabetes Mellitus
Location: Philadelphia, PA
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-19713
Conditions: Type 2 Diabetes Mellitus
Location: Newark, DE
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-20852
Conditions: Type 2 Diabetes Mellitus
Location: Rockville, MD
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-23502
Conditions: Type 2 Diabetes Mellitus
Location: Virginia Beach, VA
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-32835
Conditions: Type 2 Diabetes Mellitus
Location: Orlando, FL
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-38138
Conditions: Type 2 Diabetes Mellitus
Location: Germantown, TN
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-48114
Conditions: Type 2 Diabetes Mellitus
Location: Brighton, MI
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-58103
Conditions: Type 2 Diabetes Mellitus
Location: Fargo, ND
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-70808
Conditions: Type 2 Diabetes Mellitus
Location: Baton Rouge, LA
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-71913
Conditions: Type 2 Diabetes Mellitus
Location: Hot Springs, AR
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-72205
Conditions: Type 2 Diabetes Mellitus
Location: Little Rock, AR
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-72653
Conditions: Type 2 Diabetes Mellitus
Location: Mountain Home, AR
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-75093
Conditions: Type 2 Diabetes Mellitus
Location: Plano, TX
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-75230
Conditions: Type 2 Diabetes Mellitus
Location: Dallas, TX
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-77081
Conditions: Type 2 Diabetes Mellitus
Location: Houston, TX
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-85206
Conditions: Type 2 Diabetes Mellitus
Location: Mesa, AZ
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-94520
Conditions: Type 2 Diabetes Mellitus
Location: Concord, CA
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine - NCT00975286-94904
Conditions: Type 2 Diabetes Mellitus
Location: Greenbrae, CA
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes - NCT00993473-14222
Conditions: Type 1 Diabetes Mellitus
Location: Buffalo, NY
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes - NCT00993473-19107
Conditions: Type 1 Diabetes Mellitus
Location: Philadelphia, PA
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes - NCT00993473-21229
Conditions: Type 1 Diabetes Mellitus
Location: Baltimore, MD
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes - NCT00993473-78229
Conditions: Type 1 Diabetes Mellitus
Location: San Antonio, TX
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes - NCT00993473-80111
Conditions: Type 1 Diabetes Mellitus
Location: Greenwood Village, CO
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes - NCT00993473-95819
Conditions: Type 1 Diabetes Mellitus
Location: Sacramento, CA
- A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus - NCT00660309-02115
Conditions: Type 2 Diabetes Mellitus
Location: Boston, MA
- A Clinical Study to Evaluate the Effect of Naturlose (Tagatose) - NCT00961662-30035
Conditions: Type 2 Diabetes
Location: Decatur, GA
- A Clinical Study to Evaluate the Effect of Naturlose (Tagatose) - NCT00961662-30312
Conditions: Type 2 Diabetes
Location: Atlanta, GA
- A Clinical Study to Evaluate the Effect of Naturlose (Tagatose) - NCT00961662-33126
Conditions: Type 2 Diabetes
Location: Miami, FL
- A Clinical Study to Evaluate the Effect of Naturlose (Tagatose) - NCT00961662-77036
Conditions: Type 2 Diabetes
Location: Houston, TX
- A Clinical Study to Evaluate the Effect of Naturlose (Tagatose) - NCT00961662-92843
Conditions: Type 2 Diabetes
Location: Garden Grove, CA
- A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes - NCT00457093-93901
Conditions: Type 2 Diabetes
Location: Salinas, CA
- A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care - NCT00939250-75104
Conditions: Type 2 Diabetes - Major Depressive Disorder
Location: Cedar Hill, TX
- A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care - NCT00939250-75237
Conditions: Type 2 Diabetes - Major Depressive Disorder
Location: Dallas, TX
- A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers - NCT00741026-17033
Conditions: Insulin Resistance - Diabetes Mellitus
Location: Hershey, PA
- A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians - NCT01084928-30322
Conditions: Diabetes - Obesity
Location: Atlanta, GA
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-14609
Conditions: Diabetes Mellitus, Type 2
Location: Rochester, NY
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-23294
Conditions: Diabetes Mellitus, Type 2
Location: Richmond, VA
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-27408
Conditions: Diabetes Mellitus, Type 2
Location: Greensboro, NC
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-30342
Conditions: Diabetes Mellitus, Type 2
Location: Atlanta, GA
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-32216
Conditions: Diabetes Mellitus, Type 2
Location: Jacksonville, FL
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-34203
Conditions: Diabetes Mellitus, Type 2
Location: Bradenton, FL
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-79705
Conditions: Diabetes Mellitus, Type 2
Location: Midland, TX
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-83835
Conditions: Diabetes Mellitus, Type 2
Location: Hayden Lake, ID
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-85015
Conditions: Diabetes Mellitus, Type 2
Location: Phoenix, AZ
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-90057
Conditions: Diabetes Mellitus, Type 2
Location: Los Angeles, CA
- A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus - NCT00800176-92262
Conditions: Diabetes Mellitus, Type 2
Location: Palm Springs, CA
- A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours - NCT01065948-77025
Conditions: Diabetes
Location: Houston, TX
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-02111
Conditions: Type 1 Diabetes Mellitus
Location: Boston, MA
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-07601
Conditions: Type 1 Diabetes Mellitus
Location: Hackensack, NJ
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-07962
Conditions: Type 1 Diabetes Mellitus
Location: Morristown, NJ
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-11501
Conditions: Type 1 Diabetes Mellitus
Location: Mineola, NY
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-13210
Conditions: Type 1 Diabetes Mellitus
Location: Syracuse, NY
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-14642
Conditions: Type 1 Diabetes Mellitus
Location: Rochester, NY
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-19713
Conditions: Type 1 Diabetes Mellitus
Location: Newark, DE
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-21201
Conditions: Type 1 Diabetes Mellitus
Location: Baltimore, MD
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-23219
Conditions: Type 1 Diabetes Mellitus
Location: Richmond, VA
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-30309
Conditions: Type 1 Diabetes Mellitus
Location: Atlanta, GA
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-32207
Conditions: Type 1 Diabetes Mellitus
Location: Jacksonville, FL
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-33155
Conditions: Type 1 Diabetes Mellitus
Location: Miami, FL
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-33606
Conditions: Type 1 Diabetes Mellitus
Location: Tampa, FL
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-38103
Conditions: Type 1 Diabetes Mellitus
Location: Memphis, TN
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-40202
Conditions: Type 1 Diabetes Mellitus
Location: Louisville, KY
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-40536
Conditions: Type 1 Diabetes Mellitus
Location: Lexington, KY
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-44308
Conditions: Type 1 Diabetes Mellitus
Location: Akron, OH
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-48126
Conditions: Type 1 Diabetes Mellitus
Location: Dearborn, MI
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-52242
Conditions: Type 1 Diabetes Mellitus
Location: Iowa City, IA
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-57701
Conditions: Type 1 Diabetes Mellitus
Location: Rapid City,
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-63110
Conditions: Type 1 Diabetes Mellitus
Location: St. Louis, MI
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-64108
Conditions: Type 1 Diabetes Mellitus
Location: Kansas City, MO
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-67211
Conditions: Type 1 Diabetes Mellitus
Location: Wichita, KS
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-68131
Conditions: Type 1 Diabetes Mellitus
Location: Omaha, NE
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-70118
Conditions: Type 1 Diabetes Mellitus
Location: New Orleans, LA
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-72202
Conditions: Type 1 Diabetes Mellitus
Location: Little Rock, AR
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-72758
Conditions: Type 1 Diabetes Mellitus
Location: Rogers, AR
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-74135
Conditions: Type 1 Diabetes Mellitus
Location: Tulsa, OK
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-76104
Conditions: Type 1 Diabetes Mellitus
Location: Fort Worth, TX
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-78207
Conditions: Type 1 Diabetes Mellitus
Location: San Antonio, TX
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-83404
Conditions: Type 1 Diabetes Mellitus
Location: Idaho Falls, ID
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-85724
Conditions: Type 1 Diabetes Mellitus
Location: Tucson, AZ
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-89502
Conditions: Type 1 Diabetes Mellitus
Location: Reno, NV
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT - NCT00751842-92123
Conditions: Type 1 Diabetes Mellitus
Location: San Diego, CA
- A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics - NCT00886821-33169
Conditions: Diabetes Mellitus, Type 2
Location: Miami Gardens, FL
- A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics - NCT00886821-78229
Conditions: Diabetes Mellitus, Type 2
Location: San Antonio, TX
- A Study for Pre-Diabetic Patients With Cholesterol Lowering Drugs - NCT00831129-60637
Conditions: Pre-Diabetes
Location: Chicago, IL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-03063
Conditions: Diabetes Mellitus, Type 2
Location: Nashua, NH
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-04005
Conditions: Diabetes Mellitus, Type 2
Location: Biddeford, ME
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-04074
Conditions: Diabetes Mellitus, Type 2
Location: Scarborough, ME
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-04401
Conditions: Diabetes Mellitus, Type 2
Location: Bangor, ME
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-06050
Conditions: Diabetes Mellitus, Type 2
Location: New Britain, CT
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-08753
Conditions: Diabetes Mellitus, Type 2
Location: Toms River, NJ
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-11365
Conditions: Diabetes Mellitus, Type 2
Location: Flushing, NY
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-12206
Conditions: Diabetes Mellitus, Type 2
Location: Albany, NY
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-13210
Conditions: Diabetes Mellitus, Type 2
Location: Syracuse, NY
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-15009
Conditions: Diabetes Mellitus, Type 2
Location: Beaver, PA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-17822
Conditions: Diabetes Mellitus, Type 2
Location: Danville, PA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-18711
Conditions: Diabetes Mellitus, Type 2
Location: Wilkes Barre, PA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-19056
Conditions: Diabetes Mellitus, Type 2
Location: Levittown, PA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-19107
Conditions: Diabetes Mellitus, Type 2
Location: Philadelphia, PA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-21075
Conditions: Diabetes Mellitus, Type 2
Location: Elkridge, MD
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-27518
Conditions: Diabetes Mellitus, Type 2
Location: Cary, NC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-27713
Conditions: Diabetes Mellitus, Type 2
Location: Durham, NC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-28557
Conditions: Diabetes Mellitus, Type 2
Location: Morehead City, NC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-28803
Conditions: Diabetes Mellitus, Type 2
Location: Asheville, NC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-29412
Conditions: Diabetes Mellitus, Type 2
Location: Charleston, SC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-29572
Conditions: Diabetes Mellitus, Type 2
Location: Myrtle Beach, SC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-29605
Conditions: Diabetes Mellitus, Type 2
Location: Greenville, SC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-29651
Conditions: Diabetes Mellitus, Type 2
Location: Greer, SC
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-30308
Conditions: Diabetes Mellitus, Type 2
Location: Atlanta, GA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-32806
Conditions: Diabetes Mellitus, Type 2
Location: Orlando, FL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-33021
Conditions: Diabetes Mellitus, Type 2
Location: Hollywood, FL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-33027
Conditions: Diabetes Mellitus, Type 2
Location: Pembroke Pines, FL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-33316
Conditions: Diabetes Mellitus, Type 2
Location: Fort Lauderdale, FL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-33401
Conditions: Diabetes Mellitus, Type 2
Location: West Palm Beach, FL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-38119
Conditions: Diabetes Mellitus, Type 2
Location: Memphis, TN
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-42431
Conditions: Diabetes Mellitus, Type 2
Location: Madisonville, KY
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-43015
Conditions: Diabetes Mellitus, Type 2
Location: Delaware, OH
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-43210
Conditions: Diabetes Mellitus, Type 2
Location: Columbus, OH
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-43551
Conditions: Diabetes Mellitus, Type 2
Location: Perrysburg, OH
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-44122
Conditions: Diabetes Mellitus, Type 2
Location: Cleveland, OH
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-45242
Conditions: Diabetes Mellitus, Type 2
Location: Cincinnati, OH
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-45439
Conditions: Diabetes Mellitus, Type 2
Location: Dayton, OH
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-47591
Conditions: Diabetes Mellitus, Type 2
Location: Vincennes, IN
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-48302
Conditions: Diabetes Mellitus, Type 2
Location: Bloomfield Hills, MI
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-48503
Conditions: Diabetes Mellitus, Type 2
Location: Flint, MI
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-60012
Conditions: Diabetes Mellitus, Type 2
Location: Crystal Lake, IL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-61615
Conditions: Diabetes Mellitus, Type 2
Location: Peoria, IL
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-63141
Conditions: Diabetes Mellitus, Type 2
Location: St Louis, MO
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-66606
Conditions: Diabetes Mellitus, Type 2
Location: Topeka, KS
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-70112
Conditions: Diabetes Mellitus, Type 2
Location: New Orleans, LA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-75231
Conditions: Diabetes Mellitus, Type 2
Location: Dallas, TX
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-76014
Conditions: Diabetes Mellitus, Type 2
Location: Arlington, TX
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-78258
Conditions: Diabetes Mellitus, Type 2
Location: San Antonio, TX
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-78404
Conditions: Diabetes Mellitus, Type 2
Location: Corpus Christi, TX
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-78731
Conditions: Diabetes Mellitus, Type 2
Location: Austin, TX
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-79935
Conditions: Diabetes Mellitus, Type 2
Location: El Paso, TX
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-83404
Conditions: Diabetes Mellitus, Type 2
Location: Idaho Falls, ID
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-83646
Conditions: Diabetes Mellitus, Type 2
Location: Meridian, ID
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-83702
Conditions: Diabetes Mellitus, Type 2
Location: Boise, ID
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-84088
Conditions: Diabetes Mellitus, Type 2
Location: West Jordan, UT
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-84403
Conditions: Diabetes Mellitus, Type 2
Location: Ogden, UT
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-84790
Conditions: Diabetes Mellitus, Type 2
Location: St. George, UT
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-85028
Conditions: Diabetes Mellitus, Type 2
Location: Phoenix, AZ
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-85340
Conditions: Diabetes Mellitus, Type 2
Location: Litchfield Park, AZ
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-90723
Conditions: Diabetes Mellitus, Type 2
Location: Paramount, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-91101
Conditions: Diabetes Mellitus, Type 2
Location: Pasadena, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-91345
Conditions: Diabetes Mellitus, Type 2
Location: Mission Hills, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-91950
Conditions: Diabetes Mellitus, Type 2
Location: National City, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-92056
Conditions: Diabetes Mellitus, Type 2
Location: Oceanside, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-92201
Conditions: Diabetes Mellitus, Type 2
Location: Indio, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-92780
Conditions: Diabetes Mellitus, Type 2
Location: Tustin, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-93534
Conditions: Diabetes Mellitus, Type 2
Location: Lancaster, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-93720
Conditions: Diabetes Mellitus, Type 2
Location: Fresno, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-93940
Conditions: Diabetes Mellitus, Type 2
Location: Monterey, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-94520
Conditions: Diabetes Mellitus, Type 2
Location: Concord, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-94583
Conditions: Diabetes Mellitus, Type 2
Location: San Ramon, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-94904
Conditions: Diabetes Mellitus, Type 2
Location: Greenbrae, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-95661
Conditions: Diabetes Mellitus, Type 2
Location: Roseville, CA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-96813
Conditions: Diabetes Mellitus, Type 2
Location: Honolulu, HI
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-97330
Conditions: Diabetes Mellitus, Type 2
Location: Corvallis, OR
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-97401
Conditions: Diabetes Mellitus, Type 2
Location: Eugene, OR
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-97701
Conditions: Diabetes Mellitus, Type 2
Location: Bend, OR
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-98405
Conditions: Diabetes Mellitus, Type 2
Location: Tacoma, WA
- A Study in Patients With Type 2 Diabetes Mellitus - NCT01064687-99202
Conditions: Diabetes Mellitus, Type 2
Location: Spokane, WA
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-19107
Conditions: Type 2 Diabetes
Location: Philadelphia, PA
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-20003
Conditions: Type 2 Diabetes
Location: Washington, DC
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-21287
Conditions: Type 2 Diabetes
Location: Baltimore, MD
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-23294
Conditions: Type 2 Diabetes
Location: Richmond, VA
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-33169A
Conditions: Type 2 Diabetes
Location: Miami, FL
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-33169B
Conditions: Type 2 Diabetes
Location: Miami Gardens, FL
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-36689
Conditions: Type 2 Diabetes
Location: Mobile, AL
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-48126
Conditions: Type 2 Diabetes
Location: Dearborn, MI
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-75230
Conditions: Type 2 Diabetes
Location: Dallas, TX
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-76014
Conditions: Type 2 Diabetes
Location: Arlington, TX
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-77375
Conditions: Type 2 Diabetes
Location: Tomball, TX
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-78229
Conditions: Type 2 Diabetes
Location: San Antonio, TX
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-83702
Conditions: Type 2 Diabetes
Location: Boise, ID
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-84107
Conditions: Type 2 Diabetes
Location: Salt Lake City, UT
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-87131
Conditions: Type 2 Diabetes
Location: Albuquerque, NM
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-91911
Conditions: Type 2 Diabetes
Location: Chula Vista, CA
- A Study of LY2189102 in Patients With Type 2 Diabetes - NCT00942188-94598
Conditions: Type 2 Diabetes
Location: Walnut Creek, CA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-04005
Conditions: Diabetes Mellitus, Type 2
Location: Biddeford, ME
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-06708
Conditions: Diabetes Mellitus, Type 2
Location: Waterbury, CT
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-08822
Conditions: Diabetes Mellitus, Type 2
Location: Flemington, NJ
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-13210
Conditions: Diabetes Mellitus, Type 2
Location: Syracuse, NY
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-14607
Conditions: Diabetes Mellitus, Type 2
Location: Rochester, NY
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-23510
Conditions: Diabetes Mellitus, Type 2
Location: Norfolk, VA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-27103
Conditions: Diabetes Mellitus, Type 2
Location: Winston-Salem, NC
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-27401
Conditions: Diabetes Mellitus, Type 2
Location: Greensboro, NC
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-28557
Conditions: Diabetes Mellitus, Type 2
Location: Morehead City, NC
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-29412
Conditions: Diabetes Mellitus, Type 2
Location: Charleston, SC
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-30303
Conditions: Diabetes Mellitus, Type 2
Location: Atlanta, GA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-30606
Conditions: Diabetes Mellitus, Type 2
Location: Athens, GA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-33021
Conditions: Diabetes Mellitus, Type 2
Location: Hollywood, FL
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-33401
Conditions: Diabetes Mellitus, Type 2
Location: West Palm Beach, FL
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-48075
Conditions: Diabetes Mellitus, Type 2
Location: Southfield, MI
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-48081
Conditions: Diabetes Mellitus, Type 2
Location: St Clair Shores, MI
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-48106
Conditions: Diabetes Mellitus, Type 2
Location: Ann Arbor, MI
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-59101
Conditions: Diabetes Mellitus, Type 2
Location: Billings, MT
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-62704
Conditions: Diabetes Mellitus, Type 2
Location: Springfield, IL
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-63141
Conditions: Diabetes Mellitus, Type 2
Location: St Louis, MO
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-66606
Conditions: Diabetes Mellitus, Type 2
Location: Topeka, KS
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-70006
Conditions: Diabetes Mellitus, Type 2
Location: Metairie, LA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-75230
Conditions: Diabetes Mellitus, Type 2
Location: Dallas, TX
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-77030
Conditions: Diabetes Mellitus, Type 2
Location: Houston, TX
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-78229
Conditions: Diabetes Mellitus, Type 2
Location: San Antonio, TX
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-78626
Conditions: Diabetes Mellitus, Type 2
Location: Georgetown, TX
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-80501
Conditions: Diabetes Mellitus, Type 2
Location: Longmont, CO
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-83404
Conditions: Diabetes Mellitus, Type 2
Location: Idaho Falls, ID
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-85050
Conditions: Diabetes Mellitus, Type 2
Location: Phoenix, AZ
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-85381
Conditions: Diabetes Mellitus, Type 2
Location: Peoria, AZ
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-85741
Conditions: Diabetes Mellitus, Type 2
Location: Tucson, AZ
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-89101
Conditions: Diabetes Mellitus, Type 2
Location: Las Vegas, NV
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-91345
Conditions: Diabetes Mellitus, Type 2
Location: Mission Hills, CA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-93726
Conditions: Diabetes Mellitus, Type 2
Location: Fresno, CA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-97330
Conditions: Diabetes Mellitus, Type 2
Location: Corvallis, OR
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-98003
Conditions: Diabetes Mellitus, Type 2
Location: Federal Way, WA
- A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin - NCT00734474-98405
Conditions: Diabetes Mellitus, Type 2
Location: Tacoma, WA
- A Study of LY2599506 in Patients With Type 2 Diabetes - NCT01024244-08753
Conditions: Diabetes Mellitus, Type 2
Location: Toms River, NJ
- A Study of LY2599506 in Patients With Type 2 Diabetes - NCT01024244-13210
Conditions: Diabetes Mellitus, Type 2
Location: Syracuse, NY
- A Study of LY2599506 in Patients With Type 2 Diabetes - NCT01024244-66606
Conditions: Diabetes Mellitus, Type 2
Location: Topeka, KS
- A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment - NCT00933972-98055
Conditions: Diabetes Mellitus, Type 2
Location: Renton, WA
- A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus - NCT00961909-33025
Conditions: Diabetes Mellitus, Type 2
Location: Miramar, FL
- A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus - NCT00961909-33901
Conditions: Diabetes Mellitus, Type 2
Location: Ft. Myers, FL
- A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus - NCT00961909-78209
Conditions: Diabetes Mellitus, Type 2
Location: San Antonio, TX
- A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus - NCT00961909-91911
Conditions: Diabetes Mellitus, Type 2
Location: Chula Vista, CA
- A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease - NCT01018173-
Conditions: Diabetes Mellitus, Type 2
Location: Nashua, NH
- A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease - NCT01018173-06611
Conditions: Diabetes Mellitus, Type 2
Location: Trumbull, CT
- A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease - NCT01018173-08753
Conditions: Diabetes Mellitus, Type 2
Location: Toms River, NJ
- A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease - NCT01018173-10032
Conditions: Diabetes Mellitus, Type 2
Location: New York, NY
|
|